Back to Results

A Phase 3, Multi-center, Open-label, Safety Study of Oral Edaravone Administered over 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS)

Study category: Brain and Nervous System

Is this Study for You?

Let's Get Started!




III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.

Type of Study



University of Colorado Hospital

Principal Investigator
Stacy Dixon

Stacy Dixon

Study ID

Protocol Number: 19-2377

More information available at NCT04577404

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers